ACTAVIA LIFE SCIENCES, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ACTAVIA LIFE SCIENCES, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $15.17 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2023-08-14
- ACTAVIA LIFE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2023-06-30 was -$9.99K.
- ACTAVIA LIFE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2023-03-31 was $23.77K.
- ACTAVIA LIFE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2022-12-31 was $1.39K.
- ACTAVIA LIFE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-06-30 was -$519.03K.
- ACTAVIA LIFE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$11.46K.
- ACTAVIA LIFE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$12.93K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | -$9.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $13.78K derived: sum of 2 quarters · filed 2023-08-14 | $15.17K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $23.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-15 | $25.16K 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $1.39K 10-Q · filed 2023-03-02 | ||||
| 2018-06-30 | -$519.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | -$2.51M 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | -$1.99M 10-Q · filed 2018-05-10 | ||||
| 2017-06-30 | -$758.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | -$2.30M 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | -$1.54M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | -$761.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-14 | -$2.18M 10-Q · filed 2017-03-14 | |||
| 2016-09-30 | -$1.42M 10-Q · filed 2017-03-14 | -$1.35M 10-Q · filed 2016-11-21 | |||
| 2016-06-30 | -$11.46K 10-K · filed 2016-09-28 | ||||
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-14 | $0.00 10-Q · filed 2017-03-14 | |||
| 2015-09-30 | $0.00 10-Q · filed 2017-03-14 | ||||
| 2015-06-30 | -$12.93K 10-K · filed 2016-09-28 |